Cargando…

Caracterización molecular de pacientes con cáncer colorrectal

INTRODUCTION: Colorectal cancer has a high incidence in the world population. Different molecular pathways, such as chromosomal instability, microsatellite instability, and epigenetics are involved in its development. OBJECTIVE: To perform molecular characterization in 44 individuals with sporadic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Humberto Afanador, Carlos, Palacio, Katherine Andrea, Isaza, Luis Fernando, Ahumada, Enoc, Ocampo, Carlos Mauricio, Muñetón, Carlos Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Nacional de Salud 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414253/
https://www.ncbi.nlm.nih.gov/pubmed/35866738
http://dx.doi.org/10.7705/biomedica.5957
_version_ 1784775945686614016
author Humberto Afanador, Carlos
Palacio, Katherine Andrea
Isaza, Luis Fernando
Ahumada, Enoc
Ocampo, Carlos Mauricio
Muñetón, Carlos Mario
author_facet Humberto Afanador, Carlos
Palacio, Katherine Andrea
Isaza, Luis Fernando
Ahumada, Enoc
Ocampo, Carlos Mauricio
Muñetón, Carlos Mario
author_sort Humberto Afanador, Carlos
collection PubMed
description INTRODUCTION: Colorectal cancer has a high incidence in the world population. Different molecular pathways, such as chromosomal instability, microsatellite instability, and epigenetics are involved in its development. OBJECTIVE: To perform molecular characterization in 44 individuals with sporadic colorectal cancer. MATERIALS AND METHODS: We conducted mutation analyses of the APC, KRAS, TP53 y BRAF genes using Sanger sequencing techniques; microsatellite instability was determined by capillary electrophoresis with five STR genetic markers while the methylation status of the MHL1 promotor gene was analyzed using methylation-specific PCR. RESULTS: APC, KRAS, and TP53 genes mutation frequency was 18.1%, 25%, and 4.5%, respectively; the somatic mutations detected were located more frequently in the right colon. The frequency of microsatellite instability was 27.2% and 73.1% of the tumors had the MHL1 gene methylated while 91.6% of microsatellite instability-positive tumors had the methylated MLH1 gene. The mutation profile of microsatellite stability tumors APC, KRAS, and TP53 genes was more frequent than in the microsatellite instability-positive tumors. The methylation of the MLH1 gene was the most predominant molecular alteration. CONCLUSIONS: We identified molecular alterations in different genetic pathways of the colorectal cancer patients evaluated, which are common in the carcinogenesis of this cancer. These patients showed a different mutational profile compared to other populations. Our findings confirm the molecular heterogeneity described in the development of colorectal cancer.
format Online
Article
Text
id pubmed-9414253
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Instituto Nacional de Salud
record_format MEDLINE/PubMed
spelling pubmed-94142532022-08-26 Caracterización molecular de pacientes con cáncer colorrectal Humberto Afanador, Carlos Palacio, Katherine Andrea Isaza, Luis Fernando Ahumada, Enoc Ocampo, Carlos Mauricio Muñetón, Carlos Mario Biomedica Artículo Original INTRODUCTION: Colorectal cancer has a high incidence in the world population. Different molecular pathways, such as chromosomal instability, microsatellite instability, and epigenetics are involved in its development. OBJECTIVE: To perform molecular characterization in 44 individuals with sporadic colorectal cancer. MATERIALS AND METHODS: We conducted mutation analyses of the APC, KRAS, TP53 y BRAF genes using Sanger sequencing techniques; microsatellite instability was determined by capillary electrophoresis with five STR genetic markers while the methylation status of the MHL1 promotor gene was analyzed using methylation-specific PCR. RESULTS: APC, KRAS, and TP53 genes mutation frequency was 18.1%, 25%, and 4.5%, respectively; the somatic mutations detected were located more frequently in the right colon. The frequency of microsatellite instability was 27.2% and 73.1% of the tumors had the MHL1 gene methylated while 91.6% of microsatellite instability-positive tumors had the methylated MLH1 gene. The mutation profile of microsatellite stability tumors APC, KRAS, and TP53 genes was more frequent than in the microsatellite instability-positive tumors. The methylation of the MLH1 gene was the most predominant molecular alteration. CONCLUSIONS: We identified molecular alterations in different genetic pathways of the colorectal cancer patients evaluated, which are common in the carcinogenesis of this cancer. These patients showed a different mutational profile compared to other populations. Our findings confirm the molecular heterogeneity described in the development of colorectal cancer. Instituto Nacional de Salud 2022-05-01 /pmc/articles/PMC9414253/ /pubmed/35866738 http://dx.doi.org/10.7705/biomedica.5957 Text en https://creativecommons.org/licenses/by/4.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons
spellingShingle Artículo Original
Humberto Afanador, Carlos
Palacio, Katherine Andrea
Isaza, Luis Fernando
Ahumada, Enoc
Ocampo, Carlos Mauricio
Muñetón, Carlos Mario
Caracterización molecular de pacientes con cáncer colorrectal
title Caracterización molecular de pacientes con cáncer colorrectal
title_full Caracterización molecular de pacientes con cáncer colorrectal
title_fullStr Caracterización molecular de pacientes con cáncer colorrectal
title_full_unstemmed Caracterización molecular de pacientes con cáncer colorrectal
title_short Caracterización molecular de pacientes con cáncer colorrectal
title_sort caracterización molecular de pacientes con cáncer colorrectal
topic Artículo Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414253/
https://www.ncbi.nlm.nih.gov/pubmed/35866738
http://dx.doi.org/10.7705/biomedica.5957
work_keys_str_mv AT humbertoafanadorcarlos caracterizacionmoleculardepacientesconcancercolorrectal
AT palaciokatherineandrea caracterizacionmoleculardepacientesconcancercolorrectal
AT isazaluisfernando caracterizacionmoleculardepacientesconcancercolorrectal
AT ahumadaenoc caracterizacionmoleculardepacientesconcancercolorrectal
AT ocampocarlosmauricio caracterizacionmoleculardepacientesconcancercolorrectal
AT munetoncarlosmario caracterizacionmoleculardepacientesconcancercolorrectal